Latest News

Idea Wins
Michael Sassano is one of the most respected executives in the pharmaceutical cannabis space today. He was an early investor in the cannabis industry in the United States; today he is celebrated in mainstream business and biopharma media as an international authority on developing large-scale cannabis infrastructures throughout the world and the most advanced pharmaceutical cannabinoid products.

Startup Observer

Start-ups operating in highly-regulated sectors, like the world of pharmaceuticals, have to navigate many more obstacles compared to other businesses – whether that’s understanding laws, dealing with medical boards, building trust in their company or translating insights from the laboratory to the real world. But I believe that the lessons learned from handling these obstacles can help any business grow and scale.

European Pharmaceutical Manufacturer

Michael Sassano, founder, CEO and chairman of the board, Somai Pharmaceuticals, discusses the European medical cannabis sector, and its impact on pharmaceuticals, alongside the challenges that Somai aims to address.

Technical420
All through the house, not a creature was stirring—not even a Congressperson as time ran out to advance cannabis reforms in 2022. United States politics once again upended the global cannabis market and it was a bloodbath selling spree. As if the continued 2019 drop would never end, the 2020 fake-out run foreshadowed what would come next legislatively. The Un-SAFE Banking Act, the HOPE-less Act, and the No-GRAM Act are better names for current regulatory pushes.

MMJ Daily

“A major benefit is that the European industry can learn from the work that has already been done in the United States. Still, these industries are two different worlds, and there are many hurdles ahead for the European market,” says Michael Sassano, CEO of Somai Pharmaceuticals.

Cannabis Law Report
The pharmaceutical manufacturing industry is one of the largest waste producers in the world. In the past, manufacturers paid a third-party removal company to dispose of waste.

The Fresh Toast

The majority of the world appears to be moving towards some form of cannabis regulation, with an eye towards liberalization.

Cannabis Wealth
Michael Sassano, CEO of Somai Pharmaceuticals reflects on Q3 2022.